Stocks
Nektar Therapeutics (NKTR) EBITDA US GAAP (year values) |
||||||||
| 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | |||
| EBITDA, bln rub | ? | -347.5 | -453.8 | -325.5 | -220.5 | -129.6 | -118.9 | |
| Changes by years, y/y, % | -9% | +31% | -28% | -32% | -41% | |||
Nektar Therapeutics. EBITDA US GAAP, bln rub
Nektar Therapeutics. EBITDA US GAAP, changes, %
Nektar Therapeutics. EBITDA US GAAP, sum by quarters, bln rub
Nektar Therapeutics (NKTR) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| EBITDA, bln rub | ? | -33.0 | -28.5 | -28.6 | -29.0 | -32.8 | -118.9 | |
| Changes by years, y/y, % | -70% | -38% | -13% | -23% | 0% | |||
| Changes by quarters, q/q, % | -13% | -14% | +1% | +1% | +13% | |||
